EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C31H38N2O7 |
| Net Charge | 0 |
| Average Mass | 550.652 |
| Monoisotopic Mass | 550.26790 |
| SMILES | CCCC[C@@H](C)/C=C(C)/C=C(\C)C(=O)NC1=C[C@@](O)(/C=C/C=C/C=C/C(=O)NC2=C(O)CCC2=O)[C@@H]2O[C@@H]2C1=O |
| InChI | InChI=1S/C31H38N2O7/c1-5-6-11-19(2)16-20(3)17-21(4)30(38)32-22-18-31(39,29-28(40-29)27(22)37)15-10-8-7-9-12-25(36)33-26-23(34)13-14-24(26)35/h7-10,12,15-19,28-29,34,39H,5-6,11,13-14H2,1-4H3,(H,32,38)(H,33,36)/b8-7+,12-9+,15-10+,20-16+,21-17+/t19-,28-,29-,31+/m1/s1 |
| InChIKey | TWWQHCKLTXDWBD-MVTGTTCWSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Streptomyces sp. (ncbitaxon:1931) | - | PubMed (15787434) | Strain: M045 |
| Streptomyces parvulus (ncbitaxon:146923) | - | PubMed (8460134) | Strain: Tu64 |
| Roles Classification |
|---|
| Biological Roles: | bacterial metabolite Any prokaryotic metabolite produced during a metabolic reaction in bacteria. EC 1.8.1.9 (thioredoxin reductase) inhibitor An EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of thioredoxin reductase (EC 1.8.1.9). apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. EC 2.5.1.58 (protein farnesyltransferase) inhibitor An EC 2.5.1.* (non-methyl-alkyl or aryl transferase) inhibitor that interferes with the action of protein farnesyltransferase (EC 2.5.1.58), one of the three enzymes in the prenyltransferase group. antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. marine metabolite Any metabolite produced during a metabolic reaction in marine macro- and microorganisms. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antiatherosclerotic agent A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| manumycin A (CHEBI:29623) has role antiatherosclerotic agent (CHEBI:145947) |
| manumycin A (CHEBI:29623) has role antimicrobial agent (CHEBI:33281) |
| manumycin A (CHEBI:29623) has role antineoplastic agent (CHEBI:35610) |
| manumycin A (CHEBI:29623) has role apoptosis inducer (CHEBI:68495) |
| manumycin A (CHEBI:29623) has role bacterial metabolite (CHEBI:76969) |
| manumycin A (CHEBI:29623) has role EC 1.8.1.9 (thioredoxin reductase) inhibitor (CHEBI:64670) |
| manumycin A (CHEBI:29623) has role EC 2.5.1.58 (protein farnesyltransferase) inhibitor (CHEBI:64133) |
| manumycin A (CHEBI:29623) has role marine metabolite (CHEBI:76507) |
| manumycin A (CHEBI:29623) is a enamide (CHEBI:51751) |
| manumycin A (CHEBI:29623) is a epoxide (CHEBI:32955) |
| manumycin A (CHEBI:29623) is a organic heterobicyclic compound (CHEBI:27171) |
| manumycin A (CHEBI:29623) is a polyketide (CHEBI:26188) |
| manumycin A (CHEBI:29623) is a secondary carboxamide (CHEBI:140325) |
| manumycin A (CHEBI:29623) is a tertiary alcohol (CHEBI:26878) |
| IUPAC Name |
|---|
| (2E,4E,6R)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyldeca-2,4-dienamide |
| Synonyms | Source |
|---|---|
| manumycin A | KEGG COMPOUND |
| manumycin | KEGG COMPOUND |
| (−)-manumycin A | ChEBI |
| UCF 1C | ChEBI |
| NSC 622141 | ChEBI |
| (2E,4E,6R)-N-[(1S,5S,6R)-5-Hydroxy-5-[(1E,3E,5E)-7-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-7-oxo-1,3,5-heptatrien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyl-2,4-decadienamide | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| C12111 | KEGG COMPOUND |
| HMDB0242678 | HMDB |
| CPD-18768 | MetaCyc |
| LMFA08020185 | LIPID MAPS |
| 4942813 | ChemSpider |
| Registry Numbers | Sources |
|---|---|
| CAS:52665-74-4 | ChemIDplus |
| Citations |
|---|